101 related articles for article (PubMed ID: 3002972)
1. Direct activation of Sendai virus (HVJ)-specific cell-mediated immunity of mice for second set rejection of the virus-infected syngeneic tumor by noninfectious virus-sensitized spleen cells.
Kamihira O; Nakashima I; Hasegawa T; Ando K; Isobe K; Nagase F; Hasegawa Y; Yoshida T; Kawashima K; Yoshida T
Immunol Lett; 1985; 11(2):75-81. PubMed ID: 3002972
[TBL] [Abstract][Full Text] [Related]
2. Induction of tumor resistance in mice by L1210 leukemia cells persistently infected with HVJ (Sendai virus).
Takeyama H; Kawashima K; Yamada K; Ito Y
Gan; 1979 Aug; 70(4):493-501. PubMed ID: 229053
[TBL] [Abstract][Full Text] [Related]
3. A significant role of proximity of HVJ-antigen in the generation of tumor immunity.
Kawashima K; Watanabe E; Kato Y; Suzuki H; Minami S; Isobe K; Ogura M; Nagura E; Yamada K
Gan; 1981 Dec; 72(6):955-8. PubMed ID: 6281118
[TBL] [Abstract][Full Text] [Related]
4. Aerosol vaccination with a sendai virus temperature-sensitive mutant (HVJ-pB) derived from persistently infected cells.
Iwata H; Tagaya M; Matsumoto K; Miyadai T; Yokochi T; Kimura Y
J Infect Dis; 1990 Aug; 162(2):402-7. PubMed ID: 1695654
[TBL] [Abstract][Full Text] [Related]
5. Curing of virus persistent infection in HVJ (sendai virus) carrier hamster tumor cells by transplantation.
Ogura H; Sato H; Hatano M
Gan; 1981 Aug; 72(4):498-503. PubMed ID: 6273248
[TBL] [Abstract][Full Text] [Related]
6. Relationship between tumor formation and cell-mediated immunity in hamsters with transplanted HVJ (Sendai virus)-carrying tumor cells.
Ogura H; Sato H; Tanaka J; Hatano M; Fukuda S; Morita O
Gan; 1980 Jun; 71(3):325-32. PubMed ID: 6252084
[TBL] [Abstract][Full Text] [Related]
7. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
[TBL] [Abstract][Full Text] [Related]
8. In vitro curing of persistent infection of HVJ (sendai virus) carrier tumor cells by spleen cells.
Ogura H; Sato H; Hatano M
Gan; 1981 Aug; 72(4):504-11. PubMed ID: 6171472
[TBL] [Abstract][Full Text] [Related]
9. The use of allogeneic stimulation and exogenous interleukin for syngeneic tumor rejection.
Sherburne CG; Condie RM; Nnadi EC; Adlin M
Transplant Proc; 1987 Feb; 19(1 Pt 1):628-31. PubMed ID: 3493564
[TBL] [Abstract][Full Text] [Related]
10. Immune reactivity of allogeneically pregnant mice to paternal MHC antigens on fetal and placental cells assessed by second set rejection of ascites tumor cells.
Saito M; Nakashima I; Mizoguchi K; Isobe K; Nagase F; Goto S; Tomoda Y
J Reprod Immunol; 1985 Nov; 8(2-3):139-51. PubMed ID: 4093908
[TBL] [Abstract][Full Text] [Related]
11. Cooperation between humoral factor(s) and Lyt-2+ T cells in effective clearance of Sendai virus from infected mouse lungs.
Iwai H; Yamamoto S; Otsuka Y; Ueda K
Microbiol Immunol; 1989; 33(11):915-27. PubMed ID: 2574407
[TBL] [Abstract][Full Text] [Related]
12. Common leukemia-associated antigen of DBA/2 mouse leukemia detected by tumor rejection and complement-dependent cytotoxicity assays.
Kawashima K; Takeyama H; Takahashi T; Kato Y; Watanabe E; Suzuki H; Minam S; Isobe K; Yamada K; Ito Y
Gan; 1979 Dec; 70(6):769-76. PubMed ID: 94022
[TBL] [Abstract][Full Text] [Related]
13. Involvement of fusion activity of ultraviolet light-inactivated Sendai virus in formation of target antigens recognized by cytotoxic T cells.
Sugamura K; Shimizu K; Bach FH
J Exp Med; 1978 Jul; 148(1):276-87. PubMed ID: 78960
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immunity to Sendai virus infection in mice.
Anderson MJ; Bainbridge DR; Pattison JR; Heath RB
Infect Immun; 1977 Jan; 15(1):239-44. PubMed ID: 188766
[TBL] [Abstract][Full Text] [Related]
15. Joint recognition by cytotoxic T cells of inactivated Sendai virus and products of the major histocompatibility complex.
Schrader JW; Edelman GM
J Exp Med; 1977 Mar; 145(3):523-39. PubMed ID: 233918
[TBL] [Abstract][Full Text] [Related]
16. Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity.
Kiyotani K; Takao S; Sakaguchi T; Yoshida T
Virology; 1990 Jul; 177(1):65-74. PubMed ID: 2162116
[TBL] [Abstract][Full Text] [Related]
17. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
Fortner GW; Kripke ML
J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
[TBL] [Abstract][Full Text] [Related]
18. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
Gordon WC; Prager MD
Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
[TBL] [Abstract][Full Text] [Related]
19. High-grade tumor-specific immunity induced by L1210 leukemia variants obtained from the culture of L1210 cells fused with Lesch-Nyhan fibroblasts.
Kawashima K; Nagura E; Watanabe E; Mizoguchi K; Saga S; Isobe K; Nakashima I; Yamada K; Oikawa T; Kojima K
Int J Cancer; 1983 Oct; 32(4):507-14. PubMed ID: 6618710
[TBL] [Abstract][Full Text] [Related]
20. Protection of mice against virulent virus infection by a temperature-sensitive mutant derived from an HVJ (Sendai virus) carrier culture.
Kimura Y; Aoki H; Shimokata K; Ito Y; Takano M; Hirabayashi N; Norrby E
Arch Virol; 1979; 61(4):297-304. PubMed ID: 229796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
